Eyenovia Inc. (EYEN)
LAVA Therapeutics N.V. (LVTX)
Eyenovia Inc. (EYEN)
Oculis Holding AG (OCS)
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
InnovAge Holding Corp (INNV)
InnovAge Announces Financial Results for the Fourth Quarter and Fiscal Year Ended June 30, 2025
OPTIMIZERx Corp (OPRX)
OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising
IRIDEX Corporation (IRIX)
Iridex Corporation Receives Formal Notification of Nasdaq Listing Compliance
Evofem Biosciences, Inc. (EVFM)
Henry Schein Inc (HSIC)
Alnylam Pharmaceuticals Inc (ALNY)
Verona Pharma plc (VRNA)
New Form 8-K - Verona Pharma plc Filed: 2025-09-09 AccNo: 0001104659-25-088613 Size: 209 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits